Concepedia
Statistics
Publications
42
Citations
4.8K
H-Index
30
Active since
1995
Affiliations
Progenra (United States)(Current)
University of California San Diego
Harvard University
Massachusetts General Hospital
Howard Hughes Medical Institute
Benjamin Nicholson is an author at Progenra (United States) specializing in life sciences, medicine, and oncology.
Publications per year
1995–2023
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
Dharminder Chauhan, Laurence Catley, Guilan Li et al. · Cancer Cell · 2005 · 698 citations · Full text
Medicine, Oncology, Pharmacology +14
A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
Dharminder Chauhan, Ze Tian, Benjamin Nicholson et al. · Cancer Cell · 2012 · 581 citations
Medicine, Molecular Biology, Oncology +17
Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes
Mikael Altun, Holger Kramer, Lianne I. Willems et al. · Chemistry & Biology · 2011 · 403 citations
Life Sciences, Biochemistry, Molecular Biology +11
Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis
Richard Y. Ebright, Sooncheol Lee, Ben S. Wittner et al. · Science · 2020 · 377 citations · Full text
Medicine, Cancer Biology, Molecular Biology +17
NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent
Benjamin Nicholson, G. Kenneth Lloyd, Brian Miller et al. · Anti-Cancer Drugs · 2005 · 253 citations
Medicine, Medicinal Chemistry, Pharmacology +14
1–5 of 42